West Pharmaceutical Services, Inc. WST

NYS: WST | ISIN: US9553061055   26/04/2024
360,43 USD (-2,10%)
(-2,10%)   26/04/2024

25 april 2024 · West Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend · Persbericht

11 april 2024 · West to Host First-Quarter 2024 Conference Call · Persbericht

28 februari 2024 · West to Participate in Upcoming Investor Conferences · Persbericht

20 februari 2024 · West Announces Second-Quarter 2024 Dividend · Persbericht

15 februari 2024 · West Announces Fourth-Quarter and Full-Year 2023 Results · Persbericht

7 februari 2024 · West Named to Newsweek's America's Greatest Workplaces 2024 for Diversity · Persbericht

1 februari 2024 · West to Host Fourth-Quarter and Full-Year 2023 Conference Call · Persbericht

6 december 2023 · West Announces First-Quarter 2024 Dividend · Persbericht

4 december 2023 · West Receives FDA 510(k) Clearance for Vial2Bag Advanced® 13mm Admixture Device · Persbericht

1 november 2023 · West to Participate in Upcoming Investor Conferences · Persbericht

26 oktober 2023 · West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend · Persbericht

23 oktober 2023 · West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference · Persbericht

16 oktober 2023 · West to Present on Development of Large Volume Delivery Systems, Self-injection Devices, and Prefillable Syringe Component Expertise at the PDA Conference · Persbericht

12 oktober 2023 · West to Host Third-Quarter 2023 Conference Call · Persbericht

7 september 2023 · West to Participate in Upcoming Investor Conference · Persbericht

2 augustus 2023 · West to Participate in Upcoming Investor Conference · Persbericht

27 juli 2023 · West Announces Second-Quarter 2023 Results · Persbericht

13 juli 2023 · West to Host Second-Quarter 2023 Conference Call · Persbericht

24 mei 2023 · West to Participate in Upcoming Investor Conferences · Persbericht

4 mei 2023 · West to Participate in Upcoming Investor Conference · Persbericht

Mijn selecties